Does BOTULINUM TOXIN TYPE A Cause Hypersensitivity? 526 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 526 reports of Hypersensitivity have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 14.1% of all adverse event reports for BOTULINUM TOXIN TYPE A.
526
Reports of Hypersensitivity with BOTULINUM TOXIN TYPE A
14.1%
of all BOTULINUM TOXIN TYPE A reports
326
Deaths
341
Hospitalizations
How Dangerous Is Hypersensitivity From BOTULINUM TOXIN TYPE A?
Of the 526 reports, 326 (62.0%) resulted in death, 341 (64.8%) required hospitalization, and 324 (61.6%) were considered life-threatening.
Is Hypersensitivity Listed in the Official Label?
Yes, Hypersensitivity is listed as a known adverse reaction in the official FDA drug label for BOTULINUM TOXIN TYPE A.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Hypersensitivity?
ETANERCEPT (10,846)
ADALIMUMAB (10,641)
METHOTREXATE (9,799)
TOCILIZUMAB (9,076)
ABATACEPT (8,945)
INFLIXIMAB (8,519)
RITUXIMAB (8,408)
ADAPALENE (8,356)
LEFLUNOMIDE (7,926)
CERTOLIZUMAB PEGOL (7,353)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Hypersensitivity Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE